Beaumont Financial Advisors LLC Reduces Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Beaumont Financial Advisors LLC lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 7.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 9,776 shares of the financial services provider’s stock after selling 743 shares during the quarter. Beaumont Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,328,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the business. Glass Jacobson Investment Advisors llc grew its stake in iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after buying an additional 122 shares during the last quarter. PCA Investment Advisory Services Inc. acquired a new stake in iShares Biotechnology ETF during the 2nd quarter worth approximately $28,000. Values First Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth approximately $43,000. Horizon Bancorp Inc. IN acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth approximately $44,000. Finally, Tennessee Valley Asset Management Partners acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth approximately $44,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.1 %

iShares Biotechnology ETF stock opened at $124.72 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The stock has a 50 day moving average of $135.09 and a two-hundred day moving average of $129.54.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.